Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSC Capsule-Based vs Multi-Dose Inhaler in COPD
NCT01978145Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2013
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Nov 2013; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01978145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01978145.